Old Web
English
Sign In
Acemap
>
Paper
>
ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.
ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.
2016
Jessica Anne Weir
Peter Gilliland
Marc-Aurel Fuchs
Richard Williams
Liam Murray
Patrick Bruce Johnston
Sandra Van Schaeybroeck
Keywords:
Wild type
Colorectal cancer
Cancer research
Regulator
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]